Objectives: To assess morbidity, effectiveness and quality of life (QoL) of implant of Silimed periurethral constrictor (PC) in a consecutive series of patients who had stress urinary incontinence following radical prostatectomy. Material and Methods: A prospective non-randomized study designed on patients who underwent implant of Silimed PC. Primary end point was postoperative morbidity and secondary end points were effectiveness of implant and QoL. We performed a sub-analysis of men who received previous radiation and we compared the subpopulation with radiation-naïve patients. Results: Nineteen patients (31.6%) received pelvic radiation therapy prior implant. All procedures were completed successfully with median operative time of 55 (IQR 50-62.5) min. We recorded 47 (78.3%) postoperative complications in 30 men. Twenty-three men (38.3%) developed urethral erosion at median follow-up of 27.5 (IQR 21-35) months, and 1 man (1.9%) had rectourethral fistula at 2 months. Risk of urethral erosion increased significantly among patients who received radiation (63.1 vs. 26.8%; p < 0.001). In 12 cases (20%), we recorded malfunctioning of the reservoir requiring replacement. Conclusion: The implant of Silimed device is not safe due to a high risk of urethral erosion. Careful patient selection and detailed counseling are mandatory when considering the implant of PC in adult patients.

1.
Abrams P, Cardozo L, Khoury S, et al: Incontinence. 5th International Consultation on Incontinence, Paris, February 2012. Plymouth, Health Publication Ltd., 2009.
2.
Geiger-Gritsch S, Oberaigner W, Mühlberger N, et al: Patient-reported urinary incontinence and erectile dysfunction following radical prostatectomy: results from the European Prostate Centre Innsbruck. Urol Int 2015;94:419-427.
3.
Fernández RA, García-Hermoso A, Solera-Martínez M, et al: Improvement of continence rate with pelvic floor muscle training post-prostatectomy: a meta-analysis of randomized controlled trials. Urol Int 2015;94:125-132.
4.
Bushnell DM, Martin ML, Summers KH, Svihra J, Lionis C, Patrick DL: Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOL. Qual Life Res 2005;14:1901-1913.
5.
Van der Aa F, Drake MJ, Kasyan GR, Petrolekas A, Cornu JN; Young Academic Urologists Functional Urology Group: The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol 2013;63:681-689.
6.
Lai HH, Hsu EI, Teh BS, Butler EB, Boone TB: 13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine. J Urol 2007;177:1021-1025.
7.
De O'Vilar S, Araujo L, O Vilar F, Cummer C, Lima E: Combined use of enterocystoplasty and a new type of artificial sphincter in the treatment of urinary incontinence. J Urol 1996;156:622-624.
8.
Lima RS, Barros EG, Souza CA, de O Vilar F, Lima SV: Periurethral constrictor: late results of the treatment of post prostatectomy urinary incontinence. Int Braz J Urol 2011;37:483-487.
9.
Schiavini JL, Damião R, de Resende Júnior JA, Dornas MC, Cruz Lima da Costa DS, Barros CB: Treatment of post-prostate surgery urinary incontinence with the periurethral constrictor: a retrospective analysis. Urology 2010;75:1488-1492.
10.
Schroder P, Abrams K, Andersson E, et al: Guidelines on urinary incontinence; in AG Arnheim AG (ed): EAU Guidelines. Arnheim, European Association of Urology, 2010, pp 11-28.
11.
Bauer RM, Gozzi C, Roosen A, et al: Impact of the ‘repositioning test' on postoperative outcome of retroluminar transobturator male sling implantation. Urol Int 2013;90:334-338.
12.
Kim PH, Pinheiro LC, Atoria CL, Eastham JA, Sandhu JS, Elkin EB: Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis. J Urol 2013;189:602-608.
13.
Possavino F, Preti M, Carone R, Calabrese R, Randaccio S, D'Elia C, Allais I, Cosma S, Benedetto C: Psychometric validation of the Italian version of the I-QoL questionnaire: clinical and urodynamic findings. Int Urogynecol J 2013;24:2125-2130.
14.
de O Vilar F, Araújo LA, Lima SV: Periurethral constrictor in pediatric urology: long-term followup. J Urol 2004;171:2626-2628.
15.
Farrugia MK, Lottmann HB, Neilson A, Nicholls G, Woodward M, Malone PS: Outcome of the Lima periurethral constrictor in children and adolescents: a European perspective. J Urol 2012;188(4 suppl):1555-1559.
16.
Introini C, Naselli A, Zaninetta G, Timossi L, Guaglianone S, Simone G, Papalia R, Gallucci M, Puppo P: Safety and efficacy of periurethral constrictor implantation for the treatment of post-radical prostatectomy incontinence. Urology 2012;79:1175-1178.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.